How many stocks are there of Centogene?
The current number of stocks of Centogene is 28.16 M undefined.
Centogene Stocks 2024
Centogene Stocks
28.16 M
Ticker
CNTGF
ISIN
NL0014040206
WKN
A2PUCU
In 2024, Centogene had 28.16 M outstanding stocks, a 0% change from the 28.16 M stocks in the previous year.
The Centogene Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2024e | 28.16 |
| 2023 | 28.16 |
| 2022 | 26.81 |
| 2021 | 22.44 |
| 2020 | 20.91 |
| 2019 | 19.86 |
| 2018 | 19.86 |
| 2017 | 19.86 |
| 2016 | 19.86 |
Centogene shares outstanding NL0014040206 · A2PUCU
The number of shares was Centogene in 2023 — This indicates how many shares 28.163 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Centogene earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Centogene's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Centogene’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Centogene's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2016 | 19.86 M Aktien |
| 2017 | 19.86 M Aktien |
| 2018 | 19.86 M Aktien |
| 2019 | 19.86 M Aktien |
| 2020 | 20.91 M Aktien |
| 2021 | 22.44 M Aktien |
| 2022 | 26.81 M Aktien |
| 2023 | 28.16 M Aktien |
| 2024e | 28.16 M Aktien |
Centogene Aktienanalyse
What does Centogene do?
Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Centogene's Shares Outstanding
Centogene's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Centogene’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Centogene’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Centogene’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Centogene stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Centogene are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Centogene evolved in recent years?
The number of shares of Centogene has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Centogene as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Centogene?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Centogene pay?
Over the past 12 months, Centogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Centogene is expected to pay a dividend of 0 EUR.
What is the dividend yield of Centogene?
The current dividend yield of Centogene is .
When does Centogene pay dividends?
Centogene pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Centogene?
Centogene paid dividends every year for the past 0 years.
What is the dividend of Centogene?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Centogene located?
Centogene is assigned to the 'Health' sector.
Wann musste ich die Aktien von Centogene kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Centogene from 10/2/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Centogene pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Centogene in the year 2023?
In the year 2023, Centogene distributed 0 EUR as dividends.
In which currency does Centogene pay out the dividend?
The dividends of Centogene are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Centogene stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Centogene
Our stock analysis for Centogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Centogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.